Entrada Therapeutics, Inc. (TRDA) vs Yarrow Bioscience, Inc (YARW)
- Entrada Therapeutics, Inc. TRDA 4.36 −8.79%
- Yarrow Bioscience, Inc YARW 18.78 −6.10%
Entrada Therapeutics, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Entrada Therapeutics, Inc. and Yarrow Bioscience, Inc are of similar size ($188.8M and $186.1M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −94.1%. Entrada Therapeutics, Inc. has the higher net margin (−3,537.7% vs −3,881.5%) and the lower return on invested capital (−1,060.2% vs 0.00%). Across the 15 metrics below, Entrada Therapeutics, Inc. leads on 8 and Yarrow Bioscience, Inc on 7.
Valuation
Profitability
| Metric | TRDA | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (3,767.07%) | (4,134.44%) | 0.00% |
| Net margin | (3,537.73%) | (3,881.54%) | 0.00% |
| Free cash flow margin | (2,867.07%) | (3,513.07%) | 0.00% |
| Return on equity | (54.09%) | (61.40%) | (56.36%) |
| Return on assets | (44.35%) | (54.77%) | (48.04%) |
| Return on invested capital | (1,060.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack